Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Chongqing Zhifei Biological Products (300122 CH)
Watchlist
130
Analysis
Health Care
•
China
Chongqing Zhifei Biological Products Company Ltd. researches, manufactures, and sells vaccines and biological products including prevention products, blood products, diagnostic reagents, and therapeutic agents.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Han'S Laser Technology In A
•
31 Aug 2026 19:53
MS-China Sep 2026 Index Rebalance: Pre-Implementation Update
MS-China enters implementation on 1 Sep with 33 ADDs and 32 DELETEs. We update post-announcement stock performance and discuss implementation trades.
Ke Yan, CFA, FRM
Follow
99 Views
Share
bullish
•
CanSino Biologics
•
21 Aug 2026 09:22
CanSino Biologics(6185 HK): Price Surged - Worth a Shot !!
CanSino Biologics (6185 HK) shares surged on the back of Moderna (MRNA US) breakthroughs with its mRNA vaccine for melanoma. Cansino was China's...
David Mudd
Follow
167 Views
Share
bullish
•
Thematic (Sector/Industry)
•
06 Jul 2023 08:55
2023H2 China Healthcare Investment Strategy and Top Pick
There're structural opportunity in China healthcare in 23H2. We advise investors not to miss out.Risks remain, offloading after rebound is...
Xinyao (Criss) Wang
Follow
825 Views
Share
bullish
•
Chery Automobile Co. Ltd.
•
10 Aug 2026 14:43
MS-China Sep 2026 Index Rebalance Forecast
We forecast 16 ADD candidates and 22 DELETE candidates for the MS-China August 2026 Quarterly Index Review, with the announcement expected after US...
Ke Yan, CFA, FRM
Follow
133 Views
Share
bullish
•
Quantitative Analysis
•
03 Aug 2026 14:30
MS-China Index Earning Revision (Jul): TENCENT, MAXSCEND MICROELECTRONICS, MEITUAN, XIAOMI, JD.COM
We analyzed MS-China's consensus for Jul 2026 and highlighted changes of EPS in TENCENT, MAXSCEND MICROELECTRONICS, MEITUAN, XIAOMI, JD.COM,...
Ke Yan, CFA, FRM
Follow
178 Views
Share
Previous
1
2
3
4
5
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x